Once-Daily Investigational Nasal Spray In Adults And Adolescents With Vasomotor Rhinitis
NCT ID: NCT00118703
Last Updated: 2017-08-21
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE3
350 participants
INTERVENTIONAL
2005-07-01
2006-02-09
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Study Of Adults And Adolescents With Vasomotor Rhinitis
NCT00117325
Perennial Allergic Rhinitis Study In Pediatric Subjects
NCT00108914
Study of GW685698X In Patients With Seasonal Allergic Rhinitis
NCT00363740
Once-Daily Investigational Nasal Spray In Adults And Adolescents With Perennial Allergic Rhinitis (PAR)
NCT00289198
Seasonal Allergic Rhinitis In Pediatric Subjects
NCT00107757
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
DOUBLE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
GW685698X
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Diagnosis of VMR (vasomotor rhinitis).
* Literate in English or native language.
Exclusion Criteria
* Use corticosteroids or other allergy medications during the study.
* Used tobacco products within the past year.
12 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
GlaxoSmithKline
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
GSK Clinical Trials
Role: STUDY_DIRECTOR
GlaxoSmithKline
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
GSK Investigational Site
Birmingham, Alabama, United States
GSK Investigational Site
Phoenix, Arizona, United States
GSK Investigational Site
Little Rock, Arkansas, United States
GSK Investigational Site
Fresno, California, United States
GSK Investigational Site
Irvine, California, United States
GSK Investigational Site
Los Angeles, California, United States
GSK Investigational Site
Orange, California, United States
GSK Investigational Site
Paramount, California, United States
GSK Investigational Site
Sacramento, California, United States
GSK Investigational Site
San Francisco, California, United States
GSK Investigational Site
San Jose, California, United States
GSK Investigational Site
Walnut Creek, California, United States
GSK Investigational Site
Englewood, Colorado, United States
GSK Investigational Site
Miami, Florida, United States
GSK Investigational Site
Sarasota, Florida, United States
GSK Investigational Site
Tallahassee, Florida, United States
GSK Investigational Site
Vero Beach, Florida, United States
GSK Investigational Site
Stockbridge, Georgia, United States
GSK Investigational Site
Chicago, Illinois, United States
GSK Investigational Site
Chicago, Illinois, United States
GSK Investigational Site
South Bend, Indiana, United States
GSK Investigational Site
Shreveport, Louisiana, United States
GSK Investigational Site
Bethesda, Maryland, United States
GSK Investigational Site
Wheaton, Maryland, United States
GSK Investigational Site
North Dartmouth, Massachusetts, United States
GSK Investigational Site
Detroit, Michigan, United States
GSK Investigational Site
Jackson, Mississippi, United States
GSK Investigational Site
St Louis, Missouri, United States
GSK Investigational Site
Brick, New Jersey, United States
GSK Investigational Site
Skillman, New Jersey, United States
GSK Investigational Site
Ithaca, New York, United States
GSK Investigational Site
Rochester, New York, United States
GSK Investigational Site
Sylvania, Ohio, United States
GSK Investigational Site
Blue Bell, Pennsylvania, United States
GSK Investigational Site
Providence, Rhode Island, United States
GSK Investigational Site
Chattanooga, Tennessee, United States
GSK Investigational Site
Dallas, Texas, United States
GSK Investigational Site
Dallas, Texas, United States
GSK Investigational Site
San Antonio, Texas, United States
GSK Investigational Site
South Burlington, Vermont, United States
GSK Investigational Site
Winnipeg, Manitoba, Canada
GSK Investigational Site
Hamilton, Ontario, Canada
GSK Investigational Site
Ottawa, Ontario, Canada
GSK Investigational Site
Trois-Rivières, Quebec, Canada
GSK Investigational Site
Brno, , Czechia
GSK Investigational Site
Pardubice, , Czechia
GSK Investigational Site
Pilsen, , Czechia
GSK Investigational Site
Prague, , Czechia
GSK Investigational Site
Weinheim, Baden-Wurttemberg, Germany
GSK Investigational Site
Nuremberg, Bavaria, Germany
GSK Investigational Site
Wiesbaden, Hesse, Germany
GSK Investigational Site
Berlin, , Germany
GSK Investigational Site
Berlin, , Germany
GSK Investigational Site
Berlin, , Germany
GSK Investigational Site
Oslo, , Norway
GSK Investigational Site
Oslo, , Norway
GSK Investigational Site
Ponce, , Puerto Rico
GSK Investigational Site
Bucharest, , Romania
GSK Investigational Site
Iași, , Romania
Countries
Review the countries where the study has at least one active or historical site.
Study Documents
Access uploaded study-related documents such as protocols, statistical analysis plans, or lay summaries.
Document Type: Dataset Specification
For additional information about this study please refer to the GSK Clinical Study Register
View DocumentDocument Type: Clinical Study Report
For additional information about this study please refer to the GSK Clinical Study Register
View DocumentDocument Type: Annotated Case Report Form
For additional information about this study please refer to the GSK Clinical Study Register
View DocumentDocument Type: Informed Consent Form
For additional information about this study please refer to the GSK Clinical Study Register
View DocumentDocument Type: Individual Participant Data Set
For additional information about this study please refer to the GSK Clinical Study Register
View DocumentDocument Type: Study Protocol
For additional information about this study please refer to the GSK Clinical Study Register
View DocumentDocument Type: Statistical Analysis Plan
For additional information about this study please refer to the GSK Clinical Study Register
View DocumentRelated Links
Access external resources that provide additional context or updates about the study.
Researchers can use this site to request access to anonymised patient level data and/or supporting documents from clinical studies to conduct further research.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
FFR30007
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.